Purpose: The antiemetic effectiveness of ondansetron 8 mg i.v., ondansetron 32 mg i.v., and granisetron 10 µg/kg or 1 mg i.v. as prophylaxis in breast cancer patients receiving cyclophosphamide ...

To our knowledge, no prospective head-to-head clinical trials comparing ondansetron 8 mg with ondansetron 32 mg and granisetron 1 ... and more use of rescue antiemetics in response to the onset ...